Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate.

Williamson RT.

Br Med J. 1901 Mar 30;1(2100):760-2. No abstract available.

2.

Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors.

Wagner JA, Wright EC, Ennis MM, Prince M, Kochan J, Nunez DJ, Schneider B, Wang MD, Chen Y, Ghosh S, Musser BJ, Vassileva MT.

Clin Pharmacol Ther. 2009 Dec;86(6):619-25. doi: 10.1038/clpt.2009.88. Epub 2009 Jun 24.

PMID:
19553931
3.

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.

Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, Shoelson SE.

Clin Transl Sci. 2008 May;1(1):36-43. doi: 10.1111/j.1752-8062.2008.00026.x.

4.

Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans.

Pierce GL, Lesniewski LA, Lawson BR, Beske SD, Seals DR.

Circulation. 2009 Mar 10;119(9):1284-92. doi: 10.1161/CIRCULATIONAHA.108.804294. Epub 2009 Feb 23.

5.

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

Koska J, Ortega E, Bunt JC, Gasser A, Impson J, Hanson RL, Forbes J, de Courten B, Krakoff J.

Diabetologia. 2009 Mar;52(3):385-93. doi: 10.1007/s00125-008-1239-x. Epub 2008 Dec 23.

6.

Uric acid and cardiovascular risk.

Feig DI, Kang DH, Johnson RJ.

N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885. Review. No abstract available. Erratum in: N Engl J Med. 2010 Jun 10;362(23):2235.

7.

Salicylates increase insulin secretion in healthy obese subjects.

Fernández-Real JM, López-Bermejo A, Ropero AB, Piquer S, Nadal A, Bassols J, Casamitjana R, Gomis R, Arnaiz E, Pérez I, Ricart W.

J Clin Endocrinol Metab. 2008 Jul;93(7):2523-30. doi: 10.1210/jc.2007-1212. Epub 2008 May 6.

PMID:
18460568
8.

Variations in DNA elucidate molecular networks that cause disease.

Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ, Zhang C, Lamb J, Edwards S, Sieberts SK, Leonardson A, Castellini LW, Wang S, Champy MF, Zhang B, Emilsson V, Doss S, Ghazalpour A, Horvath S, Drake TA, Lusis AJ, Schadt EE.

Nature. 2008 Mar 27;452(7186):429-35. doi: 10.1038/nature06757. Epub 2008 Mar 16.

9.

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, Warram JH, Krolewski AS.

Clin J Am Soc Nephrol. 2008 May;3(3):706-13. doi: 10.2215/CJN.04271007. Epub 2008 Feb 13.

10.

Salsalate improves glycemia and inflammatory parameters in obese young adults.

Fleischman A, Shoelson SE, Bernier R, Goldfine AB.

Diabetes Care. 2008 Feb;31(2):289-94. Epub 2007 Oct 24.

11.

Evaluation of the modification of diet in renal disease study equation in a large diverse population.

Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, Rahman M, Deysher AE, Zhang YL, Schmid CH, Levey AS.

J Am Soc Nephrol. 2007 Oct;18(10):2749-57. Epub 2007 Sep 12.

12.

Inflammation and metabolic disorders.

Hotamisligil GS.

Nature. 2006 Dec 14;444(7121):860-7. Review.

PMID:
17167474
13.

Inflammation and insulin resistance.

Shoelson SE, Lee J, Goldfine AB.

J Clin Invest. 2006 Jul;116(7):1793-801. Review. Erratum in: J Clin Invest. 2006 Aug;116(8):2308.

14.

Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.

Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G.

Diabetologia. 2006 Jul;49(7):1686-9. Epub 2006 May 3.

PMID:
16752187
15.

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE.

Nat Med. 2005 Feb;11(2):183-90. Epub 2005 Jan 30.

16.

IKK-beta links inflammation to obesity-induced insulin resistance.

Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M.

Nat Med. 2005 Feb;11(2):191-8. Epub 2005 Jan 30.

PMID:
15685170
17.

Aspirin and diabetes mellitus.

REID J, MACDOUGALL AI, ANDREWS MM.

Br Med J. 1957 Nov 9;2(5053):1071-4. No abstract available.

18.

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.

Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI.

J Clin Invest. 2002 May;109(10):1321-6.

19.

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE.

Science. 2001 Aug 31;293(5535):1673-7. Erratum in: Science 2002 Jan 11;295(5553):277.

20.

Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.

Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A.

Am J Kidney Dis. 2000 Jul;36(1):29-34.

PMID:
10873868

Supplemental Content

Support Center